2
Novo Nordisk last week cut its full-year guidance and named Mike Doustdar as its new CEO.
Novo Nordisk’s Wegovy weight loss drug sales soar 67% in second quarter
Explore Our Brands
- WSJ
- Barron's
- MarketWatch
- IBD
- Buy Side from WSJ
Apple Inc.
NasdaqGS
AAPL
221
USD
10.33USD
(5.09%)
Microsoft Corporation
NasdaqGS
MSFT
525
USD
-2.81USD
(-0.53%)
Amazon.com, Inc.
NasdaqGS
AMZN
229.97
USD
8.56USD
(4%)
WSJ Membership
- The Journal Collection
- Subscription Options
- Why Subscribe?
- Corporate Subscriptions
- WSJ Higher Education Program
- WSJ High School Program
- Public Library Program
- WSJ Live
- Commercial Partnerships
Customer Service
- Customer Center
- Contact Us
- Cancel My Subscription
Tools & Features
- Newsletters & Alerts
- Guides
- Topics
- My News
- RSS Feeds
- Video Center
- Watchlist
- Podcasts
- Visual Stories
Ads
- Advertise
- Commercial Real Estate Ads
- Place a Classified Ad
- Sell Your Business
- Sell Your Home
- Recruitment & Career Ads
- Digital Self Service
More
- About Us
- Content Partnerships
- Corrections
- Jobs at WSJ
- News Archive
- Register for Free
- Reprints & Licensing
- Buy Issues
- WSJ Shop
- Dow Jones Press Room
- Dow Jones Smart Money
